Cargando…
Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241983/ https://www.ncbi.nlm.nih.gov/pubmed/25386727 http://dx.doi.org/10.1038/ncomms6392 |
_version_ | 1782345924302864384 |
---|---|
author | Folcher, Marc Oesterle, Sabine Zwicky, Katharina Thekkottil, Thushara Heymoz, Julie Hohmann, Muriel Christen, Matthias Daoud El-Baba, Marie Buchmann, Peter Fussenegger, Martin |
author_facet | Folcher, Marc Oesterle, Sabine Zwicky, Katharina Thekkottil, Thushara Heymoz, Julie Hohmann, Muriel Christen, Matthias Daoud El-Baba, Marie Buchmann, Peter Fussenegger, Martin |
author_sort | Folcher, Marc |
collection | PubMed |
description | Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the transgene expression in human cells. An electroencephalography (EEG)-based brain–computer interface (BCI) processing mental state-specific brain waves programs an inductively linked wireless-powered optogenetic implant containing designer cells engineered for near-infrared (NIR) light-adjustable expression of the human glycoprotein SEAP (secreted alkaline phosphatase). The synthetic optogenetic signalling pathway interfacing the BCI with target gene expression consists of an engineered NIR light-activated bacterial diguanylate cyclase (DGCL) producing the orthogonal second messenger cyclic diguanosine monophosphate (c-di-GMP), which triggers the stimulator of interferon genes (STING)-dependent induction of synthetic interferon-β promoters. Humans generating different mental states (biofeedback control, concentration, meditation) can differentially control SEAP production of the designer cells in culture and of subcutaneous wireless-powered optogenetic implants in mice. |
format | Online Article Text |
id | pubmed-4241983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Pub. Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42419832014-12-04 Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant Folcher, Marc Oesterle, Sabine Zwicky, Katharina Thekkottil, Thushara Heymoz, Julie Hohmann, Muriel Christen, Matthias Daoud El-Baba, Marie Buchmann, Peter Fussenegger, Martin Nat Commun Article Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the transgene expression in human cells. An electroencephalography (EEG)-based brain–computer interface (BCI) processing mental state-specific brain waves programs an inductively linked wireless-powered optogenetic implant containing designer cells engineered for near-infrared (NIR) light-adjustable expression of the human glycoprotein SEAP (secreted alkaline phosphatase). The synthetic optogenetic signalling pathway interfacing the BCI with target gene expression consists of an engineered NIR light-activated bacterial diguanylate cyclase (DGCL) producing the orthogonal second messenger cyclic diguanosine monophosphate (c-di-GMP), which triggers the stimulator of interferon genes (STING)-dependent induction of synthetic interferon-β promoters. Humans generating different mental states (biofeedback control, concentration, meditation) can differentially control SEAP production of the designer cells in culture and of subcutaneous wireless-powered optogenetic implants in mice. Nature Pub. Group 2014-11-11 /pmc/articles/PMC4241983/ /pubmed/25386727 http://dx.doi.org/10.1038/ncomms6392 Text en Copyright © 2014, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Folcher, Marc Oesterle, Sabine Zwicky, Katharina Thekkottil, Thushara Heymoz, Julie Hohmann, Muriel Christen, Matthias Daoud El-Baba, Marie Buchmann, Peter Fussenegger, Martin Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
title | Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
title_full | Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
title_fullStr | Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
title_full_unstemmed | Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
title_short | Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
title_sort | mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241983/ https://www.ncbi.nlm.nih.gov/pubmed/25386727 http://dx.doi.org/10.1038/ncomms6392 |
work_keys_str_mv | AT folchermarc mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT oesterlesabine mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT zwickykatharina mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT thekkottilthushara mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT heymozjulie mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT hohmannmuriel mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT christenmatthias mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT daoudelbabamarie mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT buchmannpeter mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant AT fusseneggermartin mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant |